Immunogenicity of viral epitopes expressed on genetically and enzymatically engineered immunoglobulins

Chemical Immunology

Volumn 65, Issue , 1997, Pages 179-206

  Bona, Constantin A ^a   Bot, Adrian ^a   Brumeanu, Teodor D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN;

ANTIGEN PRESENTATION; ARTICLE; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOGLOBULIN STRUCTURE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; ENZYMES; EPITOPES; GENETIC ENGINEERING; HUMANS;

EID: 0031036286     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Jennings PA, Bills M, Irving DD, Matlick JS: Fimbriae of Batteroides nodosus: Protein engineering of the structural subunit for the production of an exogenous peptide. Protein Eng 1980;2:365-369.
2. Valenzuela P, Coit D, Medina-Selby MA, Kuo CH, VanNest G, Burke RL, Bull P, Urdea MS, Graves PV: Antigen engineering in yeast: Synthesis and assembly of hybrid hepatitis B surface antigen-Herpes simplex 1 gD particle. Biotechnology 1985;3:323-326.
3. Rutgers T, Gordon D, Gethoye A-M, Hollingdale M, Hockmeyer W, Rosenberg M, DeWilde M: Hepatitis B surface antigen as carrier matrix for the repetitive epitope of the circumsporozoite protein of Plasmodium falciparum. Biotechnology 1988;6:1065-1069.
4. Li S, Schulman JL, Moran T, Bona C, Palese P: Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. J Virol 1992;66:399-404.
5. Leclerc C (ed): Immunogenicity of foreign epitopes expressed in chimeric molecules. Int Rev Immunol 1994;11:103-178.
6. Clarke BE, Newton SE, Caroll AR, Francis MJ, Appleyard G, Syred AD, Highfield PE, Rowlands DJ, Brown F: Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 1987;330:381-384.
7. Evans DJ, McKeating J, Meredith JM, Burke KL, Katrak K, John H, Ferguson M, Minor PD, Weiss RA, Almond JW: An engineered poliovirus chimera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 1989;339:385-388.
8. Burke KL, Dunn G, Ferguson FM, Minor PD, Almond JW: Antigen chimeres of poliovirus as potential new vaccines. Nature 1988;332:81-82.
9. Del Val M, Schlicht H-J, Ruppert T, Reddehase MJ, Koszinowski UH: Efficient processing of an antigen sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 1991;66:1145-1153.
10. Zaghouani H, Krystal M, Kuzu H, Moran T, Shah H, Kuzu Y, Schulman J, Bona C: Cells expressing a heavy chain immunoglobulin gene carrying a viral T cell epitope are lysed by specific cytolytic T cells. J Immunol 1992;148:3604-3609.
11. Newton SMC, Jacob CO, Stocker BAD: Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 1989;147:70-72.
12. Sollazzo M, Billeta R, Zanetti M: Expression of an exogenous peptide epitope genetically engineered in the variable domain of an immunoglobulin: Implications for antibody and peptide folding. Bioengineering 1990;4:215-220.
13. Wyss-Coray T, Brander C, Bettens F, Mijic D, Pichler WJ: Use of antibody-peptide constructs to direct antigcnic peptides to T cells: evidence for T cell processing and presentation. Cell Immunol 1992;139:268-273.
14. McCoy KL, Noone M, Inman JK, Strutzman C: Exogenous antigens internalized through transferrin receptors activate CD4+ T cells. J Immunol 1993;150:1191-1204.
15. Mitsuda S, Nakagawa T, Nakazato H, Ikai A: Receptor-linked antigen delivery system. Biochem Biophys Res Comm 1995;216:393-405.
16. Bona C, Cazenave PA (eds): Lymphocytic Regulation by Antibodies. New York, Wiley InterScience, 1981.
17. Casten LA, Kaumaya P, Pierce SK: Enhanced T cell responses to antigen peptides targeted to B cell surface Ig la or class I molecules. J Exp Medods 1988;168:171-180.
18. Brumeanu TD, Dehazya P, Wolf I, Bona CA: Enzymatically mediated, glycosidic conjugation of immunoglobulins with viral epitopes. J Immunol Methods 1995;183:185-197.
19. Lindemann J: Homobodies: Do they exist? Ann Immunol Inst Pasteur 1973;130C:311-318.
20. Jerne NK: Towards a network theory of the immune response. Ann Immunol (Paris) 1974;125C: 373-389.
21. Bona C, Victor-Kobrin C, Manheimer A, Legrain P, Buttin G, Yancopoulos G, Alt F: in Pendura A, Doria G, Damarco F, Bargelli A (eds): Genetic and Molecular Aspects of Regulatory Idiotypes in Monoclonal Antibodies 84: Biological and Clinical Applications. Milano, Kurtis, 1985, pp 55-75.
22. Ertl HCJ, Bona C: Criteria to define anti-idiotypic antibodies carrying the internal image of an antigen. Vaccine 1988;6:80-84.
23. Nisonoff A, Lamoyi E: Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: Possible application to vaccine production. Clin Immunol Immunopathatol 1981;21:397-406.
24. 10) GAT Immune response: Comparison of VH, VK and D regions used by anti-GAT antibodies and monoclonal antibodies produced after antiidiotypic immunization. Proc Natl Acad Sci USA 1985;82:4788-4792.
25. Bailey NC, Fidanza V, Mayer R, Mazza G, Fougereau M, Bona C: Activation of clones producing self-reactive antibodies by foreign antigens and anti-idiotype antibody carrying the internal image of the antigen. J Clin Invest 1989;84:744-756.
26. Bruck C, Co SM, Slaoui M, Gaulton GN, Smith T, Fields BN, Mullins JI, Green MI: Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen. Proc Natl Acad Sci USA 1986;83:6578-6582.
27. Van Cleave WH, Naeve CW, Metzger DW: Do antibodies recognize amino acid side chains of protein antigens independently of carbon backbone. J Exp Med 1988;167:1841-1848.
28. Biletta R, Hollingdale MR, Zanetti M: Immunogenicity of an engineered internal antibody. Proc Natl Acad Sci USA 1991;88:4713-4717.
29. Lee G, Chan W, Hurle MR, DesJarlais RL, Watson F, Sathe GM, Wetzel R: Strong inhibition of fibrinogen binding to platelet receptor - αIIβ3 by RAD sequences installed into a presentation scaffold. Protein Eng 1993;6:745-754.
30. Zaghouani H, Steinman R, Nonacs R, Shah H, Gerhard W, Bona C: Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 1993;259:224-227.
31. Zaghouani H, Anderson SA, Sperber KE, Daian C, Kennedy RC, Mayer L, Bona C: Induction of antibodies to the human immunodeficiency virus type I by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Proc Natl Acad Sci USA 1995;92:631-635.
32. Brumeanu T-D, Bot A, Bona CA, Dehazya P, Wolf I, Zaghouani H: Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes. Immunotechnology 1996;2:85-95.
33. Zaghouani H, Kuzu Y, Kuzu H, Mann N, Daian C, Bona C: Engineered immunoglobulin molecules as vehicles for T cell epitopes. Int Rev Immunol 1993;10:265-278.
34. Traunecker A, Schneider J, Kiefer A, Karjalainen K: High efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature 1989;339:68-70.
35. Byrn RA, Mordenti J, Lucas C, Smith D, Marsters SA, Johnson JJ, Cossum P, Chamow SM, Wurm FM, Gregory T, Groopman JE, Capron DJ: Biological properties of a CD4 immunoadhesin. Nature 1990;344:667-669.
36. Dinca L, Zaghouani H, Brumeanu T, Mayer L, Sperber K, Bona C, Fidanza V: Effect of immunoadhesin on infection of human T cells and monocytes by HIV-1. Autoimmunity 1992;(suppl): 49.
37. Linsley PS, Brady W, Urnes M, Grosmaire L, Damle NK, Ledbetter JA: CTLA-4 is a second receptor for the B cell activation antigen B. J Exp Med 1991;174:561.
38. Tao M-H, Levy R: Idiotype/granulocyte macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 1993;362:755-758.
39. Kaufmann SHE, Eichmann K, Muller I, Wrazel LJ: Vaccination against the intracellular bacterium Listeria monocytogenes with a clonotypic antiserum. J Immunol 1985;134:4123-4127.
40. Rees A, Scoging A, Dobson N, Praputpittaya K, Young D, Ivanyi J, Lamb JR: T cell activation by anti-idiotypic antibody: Mechanism of interaction with antigen-reactive T cells. Eur J Immunol 1987;17:197-201.
41. Bona C: Antiidiotypes: in Bona C (ed): Biological Applicatons of Antiidiotypes. Boca Raton, CRC Press, 1988, vol 1, pp 1-13.
42. Chakarabarti D, Ghosh SK: Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor III MHC class I restricted CTL recognizes the processed form of idiotype. Cell Immunol 1992;144: 455-464.
43. Pride MW, Thakur A, Thanavala Y: Mimicry of the 'a' determinant of hepatitis B surface antigen by anti-idiotype antibody. J Exp Med 1993;177:127-134.
44. Weiss S, Bogen B: MHC class II-restricted presentation of intracellular antigen. Cell 1991;64:76-776.
45. Rudensky AY, Preston-Hurlbust P, Hong S-C, Beslow A, Janeway CA: Sequence analysis of peptide bound to MHC class II molecules. Nature 1991;353:622-627.
46. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992;358:764-768.
47. Taylor PM, Askonas BA: Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 1986;58:417-420.
48. Haberman AM, Moller C, McCreedy D, Gerhard WV: A large degree of functional diversity exists among helper T cells specific for the same antigenic site of influenza hemagglutinin. J Immunol 1990;145:3087-3094.
49. Townsend ARM, McMichael AJ, Carter NP, Huddleston JA, Brownlee GG: Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 1984;39:13.
50. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Genze HJ: Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991;349:669-675.
51. Kuzu Y, Kuzu H, Zaghouani H, Bona C: Priming of cytolytic T lymphocytes at various stages of ontogeny with transfectoma cells expressing a chimeric heavy chain gene bearing an influenza virus nucleoprotein peptide. Intern Immunol 1993;5:1301-1307.
52. Cao W, Myers-Powell BA, Braciale TJ: Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J Exp Med 1994;179:195-202.
53. Kouriliski P, Claveric JM: The peptide self-model: A hypothesis on the molecular nature of immunological self. Ann Inst Pasteur 1986;137D:3-12.
54. Zaghouani H, Kuzu Y, Kuzu H, Brumeanu TD, Swiggard WJ, Steinman RM, Bona CA: Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin. Eur J Immunol 1993;23:2746-2750.
55. Weber S, Trannecher A, Oliveri F, Gerhard W, Karjalainen K: Specific low affinity recognition of MHC complex plus peptide by soluble T cell receptor. Nature 1992;356:793-796.
56. Kirberg J, Baron A, Jakob S, Rolink A, Karjalainen K, von Boehmer H: Thymic selection of CD8+ single positive cells with class II MHC-restricted receptor. J Exp Med 1994;180:25-34.
57. Bentley GA, Boulot G, Karjalainen K, Mariuzza R: Crystal structure of the β chain of a T cell antigen receptor. Science 1995;267:1984-1987.
58. Brumeanu TD, Casares S, Harris PE, Dehazya P, Wolf I, von Boehmer H, Bona CA: Immunopotency of a viral peptide assembled on the carbohydrate moieties of self immunoglobulins. Nature/Biotechnology 1996;14:722-725.
59. Bot A, Bot S, Karjalainen K, Bona C: Kinetics of generation and persistence of membrane class II molecules of a viral peptide expressed on foreign and self proteins. J Immunol 1996, in press.
60. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C: Modulation of antigen presentation by bound antibodies can boost or suppress class II MHC complex presentation of different T cell determinants. J Exp Med 1995;181:1957-1963.
61. Lanzavecchia A, Reid PA, Watts C: Irreversible association of peptides with class II MHC molecules in living cells. Nature 1992;357:249-252.
62. Unanue ER: Macrophages, antigen presenting cells and the phenomenon of antigen handling and presentation: in Paul WE (ed): Fundamental Immunology. New York, Raven Press, 1989, p 95.
63. Braciale TL, Braciale VL: Antigen presentation structural themes and functional variations. Immunol Today 1992;12:124-129.
64. Germain RN, Margulies DH: The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993;11:403.
65. Brumeanu T, Swiggard WJ, Steinman RM, Bona CA, Zaghouani H: Efficient loading of identical viral peptide onto class II molecule by antigenized immunoglobulin and influenza virus. J Exp Med 1993;178:1795-1799.
66. Brumeanu TD, Dehazya P, Bot S, Casares S, Wolf I, Bona CA: MHC class II presentation of a viral epitope assembled to carbohydrate moieties of self immunoglobulins does not require antigen processing, submitted.
67. Chain BM, Bou-Gharios G, Olsen I: Endopeptidase activities associated with the plasma membrane compartment of an antigen-presenting B cell. Clin Exp Immunol 1989;75:87-92.
68. Bently GA, Boulot G, Rittot MM, Poljak RJ: Three-dimensional structure of an idiotype-anti-idiotype complex. Nature 1990;348:254.
69. Fields B, Goldbaum FA, Ysern X, Poljak RJ, Mariuzza RA: Molecular basis of antigen mimicry by an anti-idiotype. Nature 1995;374:739-742.
70. Lanza P, Billeta R, Antonenko S, Zanetti M: Active immunity against the CD4 receptor by using an antiobdy antigenized with residues 41-55 of the first extracellular domain. Proc Natl Acad Sci USA 1993;90:11683-11687.